Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Effect of Hemodialysis of on Serum Troponin I Level in Patients With Renal Disease and Normal Left Ventricular Ejection Fraction Publisher



Shemirani H1 ; Hadi N1 ; Jafarian R1 ; Sadeghi M1 ; Khosravi A1 ; Mansouri A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2022


Abstract

Background: One of the important criteria for acute myocardial ischemia is the level of troponin. The fact that troponin is excreted by the kidneys, and patients under dialysis may have a high level of it, makes the diagnosis of acute ischemia difficult. The present study aimed to evaluate the effect of hemodialysis on serum troponin I level in patients with end-stage renal disease (ESRD) and normal left ventricular ejection fraction (LVEF). Methods: In this cross-sectional study, 106 patients with ESRD and LVEF of more than 50% who underwent hemodialysis during 2018-2019 in Khorshid and Alzahra hospitals in Isfahan, Iran, were studied. The serum levels of troponin I were measured and compared before and after hemodialysis. -Findings: The mean serum level of troponin I was 0.031 ± 0.068 and 0.028 ± 0.036 ng/dl before and after hemodialysis, respectively, with no statistically difference (P = 0.590). The mean difference of troponin level before and after the hemodialysis was 0.003 ± 0.06 ng/ml. Moreover, the changes of troponin levels were not significantly associated with age, sex, duration of dialysis, hemoglobin and hematocrit levels, LVEF, cause of renal failure, and type of underlying disease. Conclusion: The findings of the present study showed that hemodialysis did not have a significant effect on changes in troponin I levels, and the level of troponin I did not appear to be a suitable biomarker for the expression of cardiovascular disease in hemodialysis patients with normal LVEF. © 2022 Isfahan University of Medical Sciences(IUMS). All rights reserved.
Experts (# of related papers)
Other Related Docs
15. Spironolactone in Chronic Hemodialysis Patients Improves Cardiac Function., Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia (2009)
19. Assessment of Hemodialysis Adequacy and Its Relationship With Individual and Personal Factors, Iranian Journal of Nursing and Midwifery Research (2016)